Icelandic gene database will uphold patients' rightsBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7186.806 (Published 20 March 1999) Cite this as: BMJ 1999;318:806
- Haraldsdóttir Ragnheidr, Deputy permanent secretary.
- Ministry of Health and Social Security, Reykjavik, Iceland
EDITOR—Berger's news story on the Icelandic gene database1 gives an inaccurate and biased account of a complex issue.
The proposed database will not exclude biotechnology companies or pharmaceutical companies from access to data on Icelandic patients, nor are exclusive rights given to one company to develop new drugs or to test candidate drugs. These studies will continue to be allowed as long …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial